Sarepta Therapeutics (NasdaqGS:SRPT) recently provided updates that may have influenced its stock performance. The announcement of a safety update for ELEVIDYS, concerning severe side effects and a ...

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney ...

The agency is considering further regulatory action after a second Duchenne patient died from acute liver failure less than two months after receiving the gene therapy.

HIVE Digital Technologies Ltd. (HIVE) on Wednesday reported a loss of $52.9 million in its fiscal fourth quarter. On a per-share basis, the Vancouver, British Columbia-based company said it had a loss ...